Skip to main content

Table 1 Socio- demographic and inclusion characteristics of the study population

From: Risk factors of severe hepatotoxicity among HIV-1 infected individuals initiated on highly active antiretroviral therapy in the Northwest Region of Cameroon

Characteristics Factors(Frequency) %
Age (years) Range < 30 years (27) 27.0
30–40 years (43) 43.0
> 40 years (30 ) 30.0
Sex Female (53) 53.0
Male (47) 47.0
BMI (kg/m2) Low (47) 47.0
Normal (31) 31.0
Overweight (7) 7.0
Obese (15) 15.0
Level of education None (5) 5.0
Primary (51) 51.0
Secondary (38) 38.0
Tertiary (6) 6.0
Monthly Income < 50,000frs (77) 77.0
> 50,000frs (23) 23.0
Alcohol intake Yes (56) 56.0
No (44) 44.0
Cigarette or Tobacco intake No (73) 73.0
Yes (27) 27.0
Year of diagnosis < 1 Year (84) 84.0
1–3 Years (4) 4.0
> 3 Years (12) 12.0
CD4 class (cells/ mm3) < 200 (57) 57.0
> 200 (43) 43.0
WHO stages stage 1 (14) 14.0
stage2 (45) 45.0
stage 3 (37) 37.0
stage 4 (4) 4.0
Drug type TDF + 3TC + EFV(64) 64.0
AZT + 3TC + EFV (22) 22.0
AZT + 3TC + NVP (14) 14.0
  1. 3TC: Lamivudine, AZT: Zidovudine, BMI: Body mass index, EFV: Efavirenz, NVP: Nevirapine; TDF: Tenofovir